Comprehensive in vitro diagnostic test system for hepatocellular carcinoma risk assessment in patients with chronic liver disease. Integrates AFP-L3 and DCP biomarker testing for improved early detection.
Manufactured by
United States
FUJIFILM Healthcare Americas Corporation is an IVD manufacturer with over 90 years of investment in R&D resulting in world-class technologies. The company provides accurate and reliable point-of-care testing solutions. Recently joined by FUJIFILM Wako Diagnostics, a provider of clinical chemistry reagents and OEM partnerships, the company offers unique and reliable IVD assays and innovative instrumentation. Featured assays include Complement Activity (CH50), Non-Esterified Fatty Acid (NEFA), and HCC Biomarkers (AFP-L3 and DCP). Product offerings span OEM products, cholesterol testing, COVID testing, diabetes testing, electrolyte testing, glucose testing, hormones, veterinary products, reagents, and cancer markers.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Singlera GENOMICS (SHANGHAI) Ltd.
China · 5 relevant products
STRATEC/Diatron
Germany · 1 relevant product
HANGZHOU LAIHE BIOTECH CO.,LTD
China · 2 relevant products
66 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →14 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 97 closest product alternatives
Singlera GENOMICS (SHANGHAI) Ltd. · China
A DNA methylation-based diagnostic test for early detection and risk assessment of hepatocellular carcinoma. Provides comprehensive screening capabilities for liver cancer malignancies.
STRATEC/Diatron · Germany
In-vitro diagnostic test for detecting tumor markers and cancer-related antigens in blood and other biological samples. The test aids in cancer screening, diagnosis, and treatment monitoring.
HANGZHOU LAIHE BIOTECH CO.,LTD · China
Rapid screening assays for AFP, CEA, PSA, and other key oncology markers enabling accessible, early-stage risk stratification in community health screening and specialist oncology settings. Offers quantitative fluorescence and semi-quantitative formats with low sample volume requirements of 50–100 µL serum/plasma. Multi-marker combo panels are available.
94 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products